Corporate Presentation
Importance of nitric oxide, our pipeline, and our plans for market disruption.
Download Now-
Poster Presentation: Phase 1 Study of Ultra-High Concentration Nitric Oxide (UNO) in Relapsed or Refractory, Unresectable, Primary, or Metastatic Cutaneous and Subcutaneous Malignancies
Frederick Dirbas, Amichay Meirovitz, Jedidiah M. Monson, David Greenberg, Amir Avniel • 11/3/2023 -
Neonatal Intensive Care | Interview: Benefits of LungFit PH System Compared to Cylinder-based Systems
• Summer 2023 -
RT For Decision Makers In Respiratory Care | Market Analysis: The Impact of Cylinder-free Systems on Inhaled Nitric Oxide Delivery
• JANUARY–FEBRUARY 2023 -
Short-Term Exposure of Cancer Cells to Ultra-High Concentrations of Nitric Oxide (UNO) Activates the mPD-1/mPD-L1 Axis and Immune Responses
Yana Epshtein, Matan Goldshtein, Selena Chaisson, Jedidiah M. Monson, Matt Johnson, Gavin Choy, Hila Confino • 04/19/2023 -
Intratumoral Administration of Ultra High-Concentration Nitric Oxide (UNO) is more Efficacious than anti-mPD-1 Therapy in 4T1 Tumor-Bearing Mice
Yana Epshtein, Matan Goldshtein, Selena Chaisson, Jedidiah M. Monson, Matt Johnson, Gavin Choy, Hila Confino • 04/19/2023 -
Respiratory Therapy: The Journal of Pulmonary Technique. Nitric Oxide from Room Air: The Development of the LungFit PH Technology.
Respiratory Therapy Vol. 18 No. 2 • Spring 2023 -
Intratumoral Administration of High-Concentration Nitric Oxide and Anti PD-1 Treatment Leads to Higher Tumor Regression Rates and Prolonged Survival in CT26 Tumor-Bearing Mice – Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
Hila Confino, David Greenberg, Selena Chaisson, Jedd Monson, Steve Lisi, Amir Avniel, Ido Wolf, Yana Epshtein • 11/10/2022 -
Characterization of Inhaled Nitric Oxide (iNO) for the treatment of Viral Community Acquired Pneumonia (VCAP)
T. Wolak, et al. • October 22, 2022 -
Home-based Treatment of Nontuberculous Mycobacteria (NTM) Pulmonary Disease Via a Novel Nitric Oxide Generator and Delivery System
Rachel Thomson, MBBS PhD FRACP • October 15, 2022 -
Home-based Intermittent Inhaled High-Dose Nitric Oxide (NO) in Nontuberculous Mycobacterial Pulmonary Disease Using a Novel NO Generator and Delivery System is Safe and Well-Tolerated. American Thoracic Society Conference 2022
R. Thomson, et al. (2022) • May 13-18, 2022
Sign up for updates from Beyond Air, Inc.
Unsubscribe from all email communications. Unsubscribe